Medicare Enrolled
Dr. Susan Federoff, MD
Family Medicine · Wexford, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Federoff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Federoff?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Federoff
Dr. Susan Federoff is a family medicine specialist in Wexford, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Federoff performed 2,090 Medicare services across 1,640 unique beneficiaries.
Between the years covered by Open Payments, Dr. Federoff received a total of $9,917 from 61 pharmaceutical and/or device companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Federoff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in PA
$9,917 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,090
Medicare services
Top 8% in PA for family medicine
1,640
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
550 | $57 | $115 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
494 | $83 | $150 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
209 | $56 | $100 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
158 | $125 | $300 |
| Annual alcohol misuse screening, 5 to 15 minutes | 150 | $18 | $30 |
| Annual depression screening | 131 | $18 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
62 | $29 | $35 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
56 | $75 | $82 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
46 | $3 | $20 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
35 | $41 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $105 | $195 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $10 | $45 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
24 | $9 | $75 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
24 | $162 | $300 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
20 | $16 | $30 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
19 | $282 | $300 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
19 | $29 | $35 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
17 | $161 | $300 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
15 | $17 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,917
Total received (2018-2024)
Avg $1,417/year across 7 years
Top 6% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
635
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,756 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$253
2023
$3,064
2022
$2,052
2021
$2,000
2020
$832
2019
$947
2018
$769
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Exact Sciences Corporation
$65
Novo Nordisk Inc
$50
ABBVIE INC.
$43
Solventum Corporation
$25
Abbott Laboratories
$21
GlaxoSmithKline, LLC.
$18
Phathom Pharmaceuticals, Inc.
$16
Currax Pharmaceuticals LLC
$15
Top 3 companies account for 62.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,399
ABBVIE INC.
$933
GlaxoSmithKline, LLC.
$791
PFIZER INC.
$742
Amgen Inc.
$700
AstraZeneca Pharmaceuticals LP
$552
Lilly USA, LLC
$547
AbbVie Inc.
$399
Amarin Pharma Inc.
$265
Astellas Pharma US Inc
$233
IDORSIA PHARMACEUTICALS US INC
$225
Daiichi Sankyo Inc.
$204
Takeda Pharmaceuticals U.S.A., Inc.
$183
Biohaven Pharmaceuticals, Inc.
$174
E.R. Squibb & Sons, L.L.C.
$168
Merck Sharp & Dohme Corporation
$154
Merck Sharp & Dohme LLC
$152
Amneal Pharmaceuticals LLC
$145
Exact Sciences Corporation
$144
Janssen Pharmaceuticals, Inc
$140
Biohaven Pharmaceutical Holding Company Ltd.
$127
Currax Pharmaceuticals LLC
$116
Teva Pharmaceuticals USA, Inc.
$106
Eisai Inc.
$101
Indivior Inc.
$100
Gilead Sciences, Inc.
$73
Ironshore Pharmaceuticals Inc.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Neos Therapeutics, LP
$58
kaleo, Inc.
$57
Xeris Pharmaceuticals, Inc.
$55
SANOFI-AVENTIS U.S. LLC
$49
Esperion Therapeutics, Inc.
$43
Inari Medical, Inc.
$38
Allergan, Inc.
$38
AbbVie, Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$37
Seqirus USA Inc
$36
Abbott Laboratories
$35
Tactile Systems Technology Inc
$34
Shire North American Group Inc
$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$30
Supernus Pharmaceuticals, Inc.
$30
Edwards Lifesciences Corporation
$28
Bausch Health US, LLC
$25
Tris Pharma Inc
$25
Solventum Corporation
$25
Collegium Pharmaceutical, Inc.
$24
Bioventus LLC
$20
Promius Pharma LLC
$18
Flexion Therapeutics, Inc.
$17
Gemini Laboratories, LLC
$16
Phathom Pharmaceuticals, Inc.
$16
BioDelivery Sciences International, Inc.
$15
Medline Industries, Inc.
$15
Noden Pharma USA Inc
$14
IBSA Pharma Inc.
$13
Nalpropion Pharmaceuticals LLC
$12
Nalpropion Pharmaceuticals, Inc.
$12
Allergan Inc.
$12
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
ACTIV.A.C. · ADVAIR · APLENZIN · AUVI-Q · Adzenys XR-ODT · Aimovig · AirDuo Digihaler · Amitiza · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · Cologuard Collection Kit · Dayvigo · Dyanavel XR · ELIQUIS · ELYXYB - celecoxib · EMGALITY · EVENITY · Evekeo · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) · FREESTYLE LIBRE 2 · Flexitouch Plus · Fluad Quadrivalent · GARDASIL 9 · GATTEX · GVOKE PFS · Humira · INJECTAFER · JANUVIA · JARDIANCE · JORNAY PM · KEVEYIS · Kerendia · LYRICA · M-M-R II · MOUNJARO · MYRBETRIQ · Motegrity · NEXLETOL · NURTEC ODT · ONZETRA XSAIL · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · PluroGel Burn & Wound Dressings · Prolia · QELBREE · QULIPTA · QUVIVIQ · ROTATEQ · Repatha · Rybelsus · S · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · SUBLOCADE · SYNTHROID · Saxenda · Supartz FX Sodium Hyaluronate · TEKTURNA · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TRUMENBA · Tirosint · Trintellix · UBRELVY · UNITHROID · VERQUVO · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · Zembrace · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
778
Per 100K population
62.7
County median income
$76,393
Nearest hospital
AHN WEXFORD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Federoff is a clinical cardiology specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement in the top 6% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Federoff experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Federoff performed 550 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Federoff receive payments from pharmaceutical companies?
Yes. Dr. Federoff received a total of $9,917 from 61 companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Federoff's costs compare to other family medicine physicians in Wexford?
Dr. Federoff's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Federoff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Wexford
Browse family medicine physicians in Wexford ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology